Use of regulators and inhibitors of Pim-1, a serine/threonine kinase, for tumour therapy (Review)

By Liang Chen   Li Ying-Yi  

Molecular Medicine Reports, Vol. 9, Iss. 6, 2014-06 ,pp. : 2051-2060

Spandidos Publications

Access to resources Recommend Favorite

Hypersensitivity to Aurora Kinase Inhibitors in Cells Resistant against Platinum- Containing Anticancer Agents

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 14, Iss. 7, 2014-09 ,pp. : 1042-1050

Bentham Science Publishers

Access to resources Recommend Favorite

Kinase Inhibitors in Prostate Cancer

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 9, Iss. 10, 2009-12 ,pp. : 1089-1104

Bentham Science Publishers

Access to resources Recommend Favorite

T-18, a stemonamide synthetic intermediate inhibits Pim kinase activity and induces cell apoptosis, acting as a potent anticancer drug

By                

Oncology Reports, Vol. 29, Iss. 3, 2013-01 ,pp. : 1245-1251

Spandidos Publications

Access to resources Recommend Favorite

PIM1 kinase as a promise of targeted therapy in prostate cancer stem cells (Review)

By Xie Yingqiu   Bayakhmetov Samat  

Molecular and Clinical Oncology, Vol. 4, Iss. 1, 2016-01 ,pp. : 13-17

Science Publishers

Access to resources Recommend Favorite